The Nifty opened at 14364.90 with a gap up of 54 points. The index first moved down and recorded its intraday low at 14274.90 and then rallied. Prices have seen an upside move of almost 100 points and then spent the afternoon session within that range. A sharp rally began around 1:30 PM which took prices to its intraday high at 14528.90. The index finally closed at 14504.80 near its day high with a gain of 194 points. The AUTO, Financial, Metal and Banks have led the bulls while IT and Pharma have closed with a loss. On Monday we had a downside day while Tuesday Nifty did the complete opposite by closing near its day high. It was a trend day on the upside. Back to Back large range days are a sign of a likely consolidation. The index is finding support near 14300-14400. This is a strong support zone. Strong resistance is visible around 14800-14900 zones. It is a very wide range so it is not very easy to trade short term. We have also seen many false breakouts and breakdowns from this range.


Bank Nifty opened at 30901 up by 109 points from Mondays close. After opening prices traded with a positive bias. In the first half, after the initial move, price traded sideways between 31000-31300 level. In the second half prices have given a breakout and a strong move of almost 1000 points with the index closing at 31771.60. It was a trend day on the upside for the bank index. Both PSU and Private banks have performed well and closed with strong gains.

Trade AnyTime AnyWhere With Elite Empower Mobile App



Stocks Price %Chg Total Qty Delivery Del % % Change
Sectors Price Change % Quantity
Icici Lombard General In 1364 0.96 748685 647689 71.8 Nifty Auto 9818.3 4.28 89007
Hdfc Ltd. 2512.95 3.85 3832030 2422529 64.21 Nifty Metal 4337.9 3.38 89007
Hdfc Life Insurance Comp 706.1 2.74 4171978 2203111 63.72 Nifty Bank 31771.6 3.18 89007
Hindustan Unilever Ltd 2454.4 -0.31 1811781 1433992 63.4 Nifty Realty 315.65 2.77 89007
Petronet Lng Limited 224.95 1.44 3842269 3098086 59.15 Nifty Energy 17672.8 2.28 89007
City Union Bank Ltd. 162.45 1.79 1422539 2048182 57.18 Nifty Media 1457.05 1.83 89007
Godrej Cons Products Ltd 723.5 1.13 913053 1163032 55.21 Nifty 50 14504.8 1.36 89007
Power Grid Corporation o 208.75 3.78 11154981 5647078 54.14 Nifty Fmcg 34720.35 0.46 89007
Trent Limited 729.25 2.6 437329 494213 53.62 Nifty Pharma 12807.5 -1.19 89007
Balkrishna Ind. Ltd 1673.85 4.21 539257 422858 53.31 Nifty it 25851.3 -3.28 89007

Get All Your Mutual Fund Portfolio Retuns on Your Mobile by Elite Kuber App



   Domestic                                                                                                                                                  International
INR:  WPI Inflation (YoY) (Mar) on 15th  April 2021

INR:  Trade Balance (Mar) on 15th  April, 2021

•USD : Crude Oil Inventories on 14th April, 2021

•USD:  Initial Jobless Claims on 15th April, 2021


Get Stock Market Recommendation By Our Research AnalystsMarket-Research-Promotional-Banner-img5

•JSW Steel’s Italian subsidiary has completed the acquisition of remaining 30.73 per cent stake in GSI Lucchini SpA of Italy for one million euros. “Pursuant to fulfilment of conditions precedent mentioned in the share purchase agreement, our subsidiary JSW Steel Italy Srl has on April 13 completed the acquisition of 30.73 per cent equity share capital of GSI,” the steelmaker informed stock exchange in regulatory filings.

•Bharti Airtel has decided to leverage its existing 4G network assets to offer 5G network technology. The firm expects to launch commercial services across the country within four to five months of getting spectrum. It expects the auctions to happen sometime at the end of this year or early next year. Non-standalone (NSA) 5G is the first or interim stage in the evolution of 5G technology which enables telcos to use their existing 4G core — the nerve centre which controls a network.

•Dr Reddy’s Laboratories (DRL), which received permission from India’s drug regulator to import the Sputnik V vaccine, could potentially mop up around $300 million from its initial sales. The company has exclusive marketing and distribution rights for the first 250 million doses of Sputnik V vaccines in the country. This is assuming a base price of around Rs 150 per dose

•Sales of Jaguar Land Rover declined by almost 14% during FY21 as the pandemic took a toll on business even as March quarter sales improved by over 12% year-on-year with sales more than doubling in China on a low base, parent Tata Motors said in a statement.

Source: Economic Times,  Indian Express  ,Business Today, Livemint, Business Standard, Bloomberg Quint


STOCK OPTION Strike Price Buy/Sell CMP Initiation Stop Loss Target Remarks
HDFC BANK 1400 CE BUY 40.50 CMP 28 60 OI increase
Long Buildup Short Buildup
Stocks Price Price% OI % OI Stocks Price Price% OI % OI
PFIZER.21.04 Apr 5123.85 7.06 85.54 150750 LALPATHLAB.21.04 Apr 2965.5 -11.22 22.71 441750
VOLTAS.21.04 Apr 962 0.87 12.09 4543000 DRREDDY.21.04 Apr 4820.95 -3.78 14.9 3848500
SRTRANSFIN.21.04 Apr 1381.1 5.92 11.67 3451200 TCS.21.04 Apr 3119.1 -3.85 9.87 9678900
AUBANK.21.04 Apr 1085.2 0.46 9.07 2579500 PIDILITIND.21.04 Apr 1810 -2.39 9.18 1939500
BAJAJFINSV.21.04 Apr 9765.9 6.53 7.57 587625 PIIND.21.04 Apr 2447 -0.83 7.6 400000
                                                                        Short Covering Long Unwinding
Stocks Price Price% OI% OI Stocks Price Price % OI % OI
FINNIFTYW.21.04 Apr 15227.75 3.25 -81.46 3040 LUPIN.21.04 Apr 1045.15 -0.26 -0.66 7651700
APOLLOTYRE.21.04 Apr 215.75 5.73 -6.72 10695000 CIPLA.21.04 Apr 890 -1.86 -0.63 12316200
CUMMINSIND.21.04 Apr 842.45 2.66 -6.57 1432800 BRITANNIA.21.04 Apr 3752 -1.85 -0.61 1845400
MARUTI.21.04 Apr 6854.9 4.78 -4.75 2452600 DIVISLAB.21.04 Apr 3736.05 -1.4 -0.56 2556200
CHOLAFIN.21.04 Apr 533.1 4.05 -4.65 5737500 GUJGASLTD.21.04 Apr 525.9 -1.69 -0.54 912500


Company Name Purpose Ex-Date Company Name Purpose Ex-Date
AMARJOTHI General 15-Apr-21 ZEXDONTR General 15-Apr-21
BLUBLND-B Quarterly Results 15-Apr-21 AARCOM Audited Results 16-Apr-21
HATHWAYB Audited Results 15-Apr-21 ASITCFIN Amalgamation;General 16-Apr-21
ICSL General 15-Apr-21 ATHENAGLO Preferential Issue of shares;General 16-Apr-21
MIDINFRA General 15-Apr-21 BLIL Increase in Authorised Capital;General 16-Apr-21
OLPCL General 15-Apr-21 DEN Audited Results;Quarterly Results 16-Apr-21
RUBRAME General 15-Apr-21 DRCSYSTEMS Preferential Issue of shares;General 16-Apr-21
SABOOBR General 15-Apr-21 GTPL Audited Results;Dividend 16-Apr-21
TINPLATE Audited Results;Dividend 15-Apr-21 MINDTREE Final Dividend;Quarterly Results 16-Apr-21
TTFL General 15-Apr-21 MMTC Quarterly Results 16-Apr-21
WIPRO Final Dividend;Quarterly Results 15-Apr-21 MODCL General 16-Apr-21

Open Your Demat Account to Invest in Upcoming IPO’sDemat-and-Trading-Account-Promotion-Banner


Company Name Ex-Date Purpose Company Name Ex-Date Purpose
FINOLEXIND 15-Apr-21 Stock  Split From Rs.10/- to Rs.2/- SANOFI 19-Apr-21 Final Dividend – Rs. – 125.00
INFRATRUST 15-Apr-21 Income Distribution (InvIT) SANOFI 19-Apr-21 Special Dividend – Rs. – 240.00
KSB 15-Apr-21 Dividend – Rs. – 8.50 SCHAEFFLER 19-Apr-21 Dividend – Rs. – 38.00
PRECTRA 15-Apr-21 Amalgamation VESUVIUS 19-Apr-21 Dividend – Rs. – 7.00
SHARDA 16-Apr-21 Stock  Split From Rs.10/- to Rs.2/- HUHTAMAKI 20-Apr-21 Final Dividend – Rs. – 3.00
ABB 19-Apr-21 Dividend – Rs. – 5.00 ASHFL 22-Apr-21 E.G.M.

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting , or e-mailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.